The rubella haemagglutination inhibition (HAl) test has been modified for the detection of rubella-specific IgM. The rubella HAl test is performed in microtitre plate wells in which IgM from patients' sera has been selectively retained by anti-human IgM bound to the polystyrene surface. The test requires only anti-human IgM-coated microtitre plates, in addition to the standard rubella HA1 reagents. The results obtained in this test, a solid-phase immunosorbent technique (SPIT), are in good agreement with results obtained by the sucrose density gradient centrifugation technique (DGCT). Advantages include the essentially unrestricted number of sera which can be tested daily, the availability of results within 24 h and the lack of interference by rheumatoid factor and by rubella-specific |gG.
INTRODUCTION
It is now well established that the identification of specific IgM antibodies is a useful tool in rapid diagnosis of acute infections. In many infections IgM antibodies persist only for a limited time and thus permit the differentiation between a recent and a past infection. The rapid determination of rubella-specific lgM in suspected infections during early pregnancy provides valuable guidance for the therapeutic resolution of the case.
Several techniques are currently in use for the determination of specific rubella lgM (Meurman, I978; . Those most commonly used diagnostically require the physical separation of lgM from IgG, either by sucrose density gradient centrifugafion (Vesikari & Vaheri, I968; Best et al. I969) or gel filtration (Gupta et al. 1970 . However, these complicated techniques severely limit the number of patients' sera which can be analysed per day.
The increasing use of solid-phase immunosorbents and their application to the separation of lgM from whole serum (Price, i977; Price & Krech, I978) prompted us to use the haemagglutination inhibition (HA1) assay for rubella-specific IgM. The solid phase (micro-titre plate wells), coated with anti-human IgM retains a fraction of the IgM from the patient's serum. Rubella-specific IgM is then determined with the standard rubella HAl test in the wells after the patient's serum has been removed. In this paper we demonstrate the simplicity of the test which allows many sera to be tested, its agreement with the conventional density gradient technique and the lack of interference from rheumatoid factor and rubellaspecific IgG.
A preliminary report of this procedure was presented at the Fourth International Congress for Virology, The Hague, The Netherlands, m978. 
Preparation of anti-human IgM-coated plates.
The conditions for optimal coating of the plates were taken from previous work (Price, 1977) . Briefly, 96-well polystyrol microtitre plates (Cooke Laboratory Products, Alexandria, Va., U.S.A.) were filled (I5O/zl per well) with a 1:4oo dilution in TSA buffer (o'05 M-tris-HC1, pH 7"4; o'I5 M-NaCI and 0"03 70 NAN3) of rabbit anti-human IgM (/z-chain-specific; Dako Immunochemicals, Denmark; lot oio5). The plates were sealed with tape and left at room temperature for I8 h and then stored at 4 °C until used (shelf life is at least 2 months)
Haemagglutinin inhibitors were removed from each serum specimen by heparin-MnCl2 treatment (Feldman, I968) , and heteroagglutinins were absorbed by incubation with sheet erythrocytes (5o/zl of a 50 ~ erythrocyte suspension per o. I ml serum). Sheep erythrocytes are used in this Institute but they can be replaced by chicken erythrocytes (G. Enders, personal communication) or human O erythrocytes (H. Lennartz, personal communication).
The anti-human IgM-coated plates were washed thoroughly with phosphate-buffered saline (PBS), shaken dry and IOO/zl of the dilutions of the patients' serum in o. I M-HEPES-HCI (pH 6.2), o'x5 M-NaC1, I ~ bovine serum albumin (HSA) buffer were added across the plate. The last well served as a control without antigen. Each series included a titration of the rubella haemagglutinating (HA) antigen. (Rubella haemagglutinin was acquired commercially from Behringwerke, Marburg, Germany.) The plates were sealed, incubated for 2 h at 37 °C, washed thoroughly with tap water and rubella HA antigen, containing I unit in 25 ~1, was added. Following incubation of the plates overnight at 4 °C, Ioo #1 of a o-2~ suspension of sheep erythrocytes was added to each well, mixed and the plates read after standing at room temperature for 2 to 3 h. Sera giving a HAl at a dilution of 1:4o or higher are considered to contain rubella-specific IgM.
Fractionation oflgM on sucrose density gradients. A I:3 dilution of serum in HS buffer (without albumin) was treated with sheep erythrocytes (50/Zl of a 50 ~ suspension per o.I ml serum), and o.2 ml of the supernatant was layered on a 4"5 ml sucrose gradient [IO to 3o 700 (w/v) sucrose in HS buffer]. After centrifugation at 35oo0 rev/min in a Beckman SW 5o. I rotor for I8 h, o'5 ml fractions were collected through the bottom of the tube, checked for IgM and IgG by immunodiffusion and the first three fractions containing IgM tested for rubella HA1 activity (Best et al. I969) .
In the determination of rubella-specific IgM by sucrose density gradient centrifugation, a fraction is considered positive only when it contains IgM (precipitation line in immunodiffusion test), is positive at least to I:4 by rubella HAI and is separated by at least one fraction from IgG-containing fractions.
RESULTS

Comparison between the solid-phase immunosorbent test (SPIT) and the density gradient centrifugation technique ( DGCT)
A series of lo4 diagnostic sera were tested independently for rubella-specific IgM by the DGCT and the SPIT. Seventy-four sera were negative in both tests and 25 were positive in both tests. Of the remaining 5 sera, 4 were positive in the SPIT only and one was positive in the DGCT but negative in the SPIT (Table I) .
Specificity of the SPIT for IgM against rubella HA
The specificity of the SPIT for rubella IgM was demonstrated by the following observations. (i) Rubella-specific IgG does not give false-positive results since sera with high (8o to 640 ) HAI titres but without clinical signs of recent infection and which are negative for rubella-specific IgM by the DGCT, are also negative (< 40) in the SPIT. This fact is well documented by the third serum taken in a late convalescent stage after clinical rubella (Table 2 ). (ii) When microtitre plates not coated with anti-human IgM are used, no HAl occurs with rubella IgM-positive sera in the SPIT. (iii) Treatment of rubella IgM-positive sera with 2-mercaptoethanol (o.2 M, 37 °C, I h) abolished the IgM titre in both the DGCT and the SPIT. (iv) When two sera, the first without a demonstrable rubella HA1 titre and the second with rubella-specific IgM, are incubated sequentially in the same wells, the titre of the positive serum is reduced from 64 ° to < 4 o. Thus, rubella-non-specific IgM can block the binding of rubella-specific IgM in the anti-human IgM-coated trays. Taken together these four controls help to confirm the specificity of the SPIT for rubella lgM.
Persistence of rubella IgM determined by the SPIT and the DGCT
Convalescent serum samples were obtained from eight patients with clinical rubella (Table 2) . Rubella-specific IgM was not detectable by either method in any serum taken from ~ I to 2o weeks after the appearance of the rash, in good agreement with Bringuier et al. (I978) and Meurman (I978). In patient R.S., no rubella IgM could be detected even at 5½ weeks after the rash. However, the clinical symptoms and increase in rubella HAI strongly suggest an acute rubella infection. It is also noteworthy that although rubella IgM disappears in convalescent sera, the rubella HAI titre does not decrease more than one dilution during this interval.
Effect of rheumatoid factor in the SPIT
As seen in Table 3 , rheumatoid factor in the presence of rubella-specific IgG does not give false-positive results -a complication often encountered in methods employing whole sera (Meurman & Ziola, I978) . Six sera with rheumatoid factor and specific rubella IgG were tested by the SPIT, but in none of these sera could specific rubella IgM be demonstrated.
DISCUSSION
The analysis of serum for rubella-specific igM antibody is laborious and uncertain. Titre reduction by treatment of whole serum by mercaptoethanol is not reproducible, especially in early convalescent sera (Vesikari & Vaheri, I968) , and removal of IgG by protein A treatment is not complete and results in apparently non-specific loss of IgM as well (Ankerst et al. I974; Handsher & Fogel, ~977) .
IgM separation from IgG by physical means, e.g. sucrose gradient centrifugation (Vesikari & Vaheri, I968; Best et al. I969) or gel filtration (Gupta et al. I97I) , are currently the most widely used methods. These complicated techniques requiring gradients, ultracentrifuges, columns and fraction collectors, severely limit the number of diagnostic sera which can be analysed per day. Great care must be taken to exclude all traces of IgG which can, even in quantitatively undetectable amounts, account for positive results in the haemagglutination inhibition test (Caul et al. 1978) .
There are several advantages to the SPIT. (i) Results are obtained within z4 h, and a large number of sera can be tested each day. (ii) In addition to the normal reagents needed for rubella HAI, only anti-human IgM-coated microtitre plates are needed. (iii) Rubellaspecific IgG cannot cause false-negative results due to competition for antigen binding as with tests using whole serum Pyndiah et al. I979) . Conversely, rubella-specific IgG does not give false-positive results when present in a serum (Table 2 ). (iv) Rheumatoid factor does not give false-positive results (Table 3 )-This can be expected since the reaction to determine the rubella specificity of the IgM antibody is actually performed on a 'purified' IgM fraction.
The sensitivity, reliability and reproducibility of the solid-phase immunosorbent test coml6ares well with the commonly used density gradient technique. Among Iz~ diagnostic sera tested (including those presented in Tables ~ and 2 ), 74 were negative and 42 positive in both tests, while 5 were positive by our criteria in only one test (Table t ; sera 26 to 3o). Three sera (27, z8, 3 o) had low IgM titres (~ : 2) after the DGCT. These titres would normally be considered to be insignificant, but all three sera yielded positive results by the SPIT. Furthermore, serum z9 was negative by the DGCT but positive by the SPIT. All patients had clinical symptoms compatible with rubella, and serum 28 came from a newborn whose mother experienced serologically confirmed rubella during pregnancy. Serum 26 gave a low titre by HAI (4o), by the DGCT (4) and was negative by the SPIT. At present there is no explanation for this discrepancy.
The titres obtained by the solid-phase method are higher than with the density gradient technique giving somewhat more confidence in questionable cases of low IgM titre, but the overall sensitivity, in terms of positive and negative, is comparable. Since the IgM rubella titre disappears equally rapidly with both techniques, there is no chance of falsely identifying a 'recent' rubella infection due to trace amounts of IgM persisting over a longer time. We conclude that the solid-phase immunosorbent test is not prone to producing any more ambiguous results than is the density gradient technique.
The technique of removing IgM by solid-phase absorbed anti-human IgM should, in addition, now be applicable to the easier and faster diagnosis of other acute infections in which HAl tests are used or where radio-or enzyme-labelled antigens are available (Price, 1977; Price & Krech, t 978) .
After the completion of this manuscript, Duermeyer & van der Veen 0978) reported the use of anti-human IgM-coated plates in an ELISA assay for specific IgM against hepatitis A virus.
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